Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India

From March to June 2021, India experienced a deadly second wave of COVID-19, with an increased number of post-vaccination breakthrough infections reported across the country. To understand the possible reason for these breakthroughs, we collected 677 clinical samples (throat swab/nasal swabs) of ind...

Full description

Bibliographic Details
Main Authors: Nivedita Gupta, Harmanmeet Kaur, Pragya Dhruv Yadav, Labanya Mukhopadhyay, Rima R. Sahay, Abhinendra Kumar, Dimpal A. Nyayanit, Anita M. Shete, Savita Patil, Triparna Majumdar, Salaj Rana, Swati Gupta, Jitendra Narayan, Neetu Vijay, Pradip Barde, Gita Nataraj, Amrutha Kumari B., Manasa P. Kumari, Debasis Biswas, Jyoti Iravane, Sharmila Raut, Shanta Dutta, Sulochana Devi, Purnima Barua, Piyali Gupta, Biswa Borkakoty, Deepjyoti Kalita, Kanwardeep Dhingra, Bashir Fomda, Yash Joshi, Kapil Goyal, Reena John, Ashok Munivenkatappa , Rahul Dhodapkar, Priyanka Pandit, Sarada Devi, Manisha Dudhmal, Deepa Kinariwala, Neeta Khandelwal, Yogendra Kumar Tiwari, Prabhat Kiran Khatri, Anjli Gupta, Himanshu Khatri, Bharti Malhotra, Mythily Nagasundaram, Lalit Dar, Nazira Sheikh, Jayanthi Shastri, Neeraj Aggarwal, Priya Abraham
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/9/1782
_version_ 1797517005663764480
author Nivedita Gupta
Harmanmeet Kaur
Pragya Dhruv Yadav
Labanya Mukhopadhyay
Rima R. Sahay
Abhinendra Kumar
Dimpal A. Nyayanit
Anita M. Shete
Savita Patil
Triparna Majumdar
Salaj Rana
Swati Gupta
Jitendra Narayan
Neetu Vijay
Pradip Barde
Gita Nataraj
Amrutha Kumari B.
Manasa P. Kumari
Debasis Biswas
Jyoti Iravane
Sharmila Raut
Shanta Dutta
Sulochana Devi
Purnima Barua
Piyali Gupta
Biswa Borkakoty
Deepjyoti Kalita
Kanwardeep Dhingra
Bashir Fomda
Yash Joshi
Kapil Goyal
Reena John
Ashok Munivenkatappa 
Rahul Dhodapkar
Priyanka Pandit
Sarada Devi
Manisha Dudhmal
Deepa Kinariwala
Neeta Khandelwal
Yogendra Kumar Tiwari
Prabhat Kiran Khatri
Anjli Gupta
Himanshu Khatri
Bharti Malhotra
Mythily Nagasundaram
Lalit Dar
Nazira Sheikh
Jayanthi Shastri
Neeraj Aggarwal
Priya Abraham
author_facet Nivedita Gupta
Harmanmeet Kaur
Pragya Dhruv Yadav
Labanya Mukhopadhyay
Rima R. Sahay
Abhinendra Kumar
Dimpal A. Nyayanit
Anita M. Shete
Savita Patil
Triparna Majumdar
Salaj Rana
Swati Gupta
Jitendra Narayan
Neetu Vijay
Pradip Barde
Gita Nataraj
Amrutha Kumari B.
Manasa P. Kumari
Debasis Biswas
Jyoti Iravane
Sharmila Raut
Shanta Dutta
Sulochana Devi
Purnima Barua
Piyali Gupta
Biswa Borkakoty
Deepjyoti Kalita
Kanwardeep Dhingra
Bashir Fomda
Yash Joshi
Kapil Goyal
Reena John
Ashok Munivenkatappa 
Rahul Dhodapkar
Priyanka Pandit
Sarada Devi
Manisha Dudhmal
Deepa Kinariwala
Neeta Khandelwal
Yogendra Kumar Tiwari
Prabhat Kiran Khatri
Anjli Gupta
Himanshu Khatri
Bharti Malhotra
Mythily Nagasundaram
Lalit Dar
Nazira Sheikh
Jayanthi Shastri
Neeraj Aggarwal
Priya Abraham
author_sort Nivedita Gupta
collection DOAJ
description From March to June 2021, India experienced a deadly second wave of COVID-19, with an increased number of post-vaccination breakthrough infections reported across the country. To understand the possible reason for these breakthroughs, we collected 677 clinical samples (throat swab/nasal swabs) of individuals from 17 states/Union Territories of the country who had received two doses (<i>n</i> = 592) and one dose (<i>n</i> = 85) of vaccines and tested positive for COVID-19. These cases were telephonically interviewed and clinical data were analyzed. A total of 511 SARS-CoV-2 genomes were recovered with genome coverage of higher than 98% from both groups. Analysis of both groups determined that 86.69% (<i>n</i> = 443) of them belonged to the Delta variant, along with Alpha, Kappa, Delta AY.1, and Delta AY.2. The Delta variant clustered into four distinct sub-lineages. Sub-lineage I had mutations in ORF1ab A1306S, P2046L, P2287S, V2930L, T3255I, T3446A, G5063S, P5401L, and A6319V, and in N G215C; Sub-lineage II had mutations in ORF1ab P309L, A3209V, V3718A, G5063S, P5401L, and ORF7a L116F; Sub-lineage III had mutations in ORF1ab A3209V, V3718A, T3750I, G5063S, and P5401L and in spike A222V; Sub-lineage IV had mutations in ORF1ab P309L, D2980N, and F3138S and spike K77T. This study indicates that majority of the breakthrough COVID-19 clinical cases were infected with the Delta variant, and only 9.8% cases required hospitalization, while fatality was observed in only 0.4% cases. This clearly suggests that the vaccination does provide reduction in hospital admission and mortality.
first_indexed 2024-03-10T07:08:52Z
format Article
id doaj.art-a4b6027c39c14c17bcd673236b8f0974
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T07:08:52Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-a4b6027c39c14c17bcd673236b8f09742023-11-22T15:37:54ZengMDPI AGViruses1999-49152021-09-01139178210.3390/v13091782Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of IndiaNivedita Gupta0Harmanmeet Kaur1Pragya Dhruv Yadav2Labanya Mukhopadhyay3Rima R. Sahay4Abhinendra Kumar5Dimpal A. Nyayanit6Anita M. Shete7Savita Patil8Triparna Majumdar9Salaj Rana10Swati Gupta11Jitendra Narayan12Neetu Vijay13Pradip Barde14Gita Nataraj15Amrutha Kumari B.16Manasa P. Kumari17Debasis Biswas18Jyoti Iravane19Sharmila Raut20Shanta Dutta21Sulochana Devi22Purnima Barua23Piyali Gupta24Biswa Borkakoty25Deepjyoti Kalita26Kanwardeep Dhingra27Bashir Fomda28Yash Joshi29Kapil Goyal30Reena John31Ashok Munivenkatappa 32Rahul Dhodapkar33Priyanka Pandit34Sarada Devi35Manisha Dudhmal36Deepa Kinariwala37Neeta Khandelwal38Yogendra Kumar Tiwari39Prabhat Kiran Khatri40Anjli Gupta41Himanshu Khatri42Bharti Malhotra43Mythily Nagasundaram44Lalit Dar45Nazira Sheikh46Jayanthi Shastri47Neeraj Aggarwal48Priya Abraham49Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi 110029, IndiaIndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi 110029, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi 110029, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaIndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi 110029, IndiaIndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi 110029, IndiaIndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi 110029, IndiaIndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi 110029, IndiaViral Research and Diagnostic Laboratory, National Institute of Research in Tribal Health (NIRTH), Jabalpur 482003, IndiaViral Research and Diagnostic Laboratory, Department of Microbiology, KEM Medical College, Mumbai 400012, IndiaViral Research and Diagnostic Laboratory, Department of Microbiology, Mysore Medical College, Mysore 570015, IndiaViral Research and Diagnostic Laboratory, Department of Microbiology, Mysore Medical College, Mysore 570015, IndiaViral Research and Diagnostic Laboratory, Department of Microbiology, All India Institute of Medical Sciences, Bhopal 462020, IndiaViral Research and Diagnostic Laboratory, Government Medical College, Aurangabad 431001, IndiaViral Research and Diagnostic Laboratory, Indira Gandhi Government Medical College, Nagpur 440012, IndiaViral Research and Diagnostic Laboratory, National Institute of Cholera and Enteric Diseases, Kolkata 700010, IndiaViral Research and Diagnostic Laboratory, Regional Institute of Medical Sciences, Imphal 795004, IndiaViral Research and Diagnostic Laboratory, Jorhat Medical College, Jorhat 785001, IndiaViral Research and Diagnostic Laboratory, Mahatma Gandhi Memorial Medical College, Jamshedpur 831020, IndiaViral Research and Diagnostic Laboratory, ICMR-Regional Medical Research Centre, Dibrugarh 786001, IndiaViral Research and Diagnostic Laboratory, All India Institutes of Medical Sciences, Rishikesh 249203, IndiaViral Research and Diagnostic Laboratory, Government Medical College, Amritsar 143001, IndiaViral Research and Diagnostic Laboratory, Sher-i-Kashmir Institute of Medical Sciences, Srinagar 190011, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaDepartment of Virology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, IndiaViral Research and Diagnostic Laboratory, Government Medical College, Thrissur 680596, IndiaICMR-National Institute of Virology Field Unit, Bangalore 560011, IndiaViral Research and Diagnostic Laboratory, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry 605006, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaViral Research and Diagnostic Laboratory, Government Medical College, Thiruvanthapuram 695011, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaViral Research and Diagnostic Laboratory, B. J. Medical College, Ahmedabad 380016, IndiaViral Research and Diagnostic Laboratory, Government Medical College, Surat 395001, IndiaViral Research and Diagnostic Laboratory, Jhalawar Medical College, Jhalawar 326001, IndiaViral Research and Diagnostic Laboratory, Dr. Sampurnanand Medical College, Jodhpur 342003, IndiaViral Research and Diagnostic Laboratory, Sarder Patel Medical College, Bikaner 334001, IndiaViral Research and Diagnostic Laboratory, Department of Microbiology, GMERS Medical College, Himmatnagar 383001, IndiaViral Research and Diagnostic Laboratory, Sawai Man Singh Medical College, Jaipur 302004, IndiaViral Research and Diagnostic Laboratory, Coimbatore Medical College, Coimbatore 641018, IndiaViral Research and Diagnostic Laboratory, All India Institute of Medical Sciences, Delhi 110029, IndiaViral Research and Diagnostic Laboratory, Dr. V.M Government Medical College, Solapur 413003, IndiaViral Research and Diagnostic Laboratory, Kasturba Hospital for Infectious Diseases, Mumbai 400011, IndiaIndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi 110029, IndiaIndian Council of Medical Research-National Institute of Virology, Pune 411021, IndiaFrom March to June 2021, India experienced a deadly second wave of COVID-19, with an increased number of post-vaccination breakthrough infections reported across the country. To understand the possible reason for these breakthroughs, we collected 677 clinical samples (throat swab/nasal swabs) of individuals from 17 states/Union Territories of the country who had received two doses (<i>n</i> = 592) and one dose (<i>n</i> = 85) of vaccines and tested positive for COVID-19. These cases were telephonically interviewed and clinical data were analyzed. A total of 511 SARS-CoV-2 genomes were recovered with genome coverage of higher than 98% from both groups. Analysis of both groups determined that 86.69% (<i>n</i> = 443) of them belonged to the Delta variant, along with Alpha, Kappa, Delta AY.1, and Delta AY.2. The Delta variant clustered into four distinct sub-lineages. Sub-lineage I had mutations in ORF1ab A1306S, P2046L, P2287S, V2930L, T3255I, T3446A, G5063S, P5401L, and A6319V, and in N G215C; Sub-lineage II had mutations in ORF1ab P309L, A3209V, V3718A, G5063S, P5401L, and ORF7a L116F; Sub-lineage III had mutations in ORF1ab A3209V, V3718A, T3750I, G5063S, and P5401L and in spike A222V; Sub-lineage IV had mutations in ORF1ab P309L, D2980N, and F3138S and spike K77T. This study indicates that majority of the breakthrough COVID-19 clinical cases were infected with the Delta variant, and only 9.8% cases required hospitalization, while fatality was observed in only 0.4% cases. This clearly suggests that the vaccination does provide reduction in hospital admission and mortality.https://www.mdpi.com/1999-4915/13/9/1782breakthroughCOVID-19VRDLDelta and Delta plus variantIndiavaccine
spellingShingle Nivedita Gupta
Harmanmeet Kaur
Pragya Dhruv Yadav
Labanya Mukhopadhyay
Rima R. Sahay
Abhinendra Kumar
Dimpal A. Nyayanit
Anita M. Shete
Savita Patil
Triparna Majumdar
Salaj Rana
Swati Gupta
Jitendra Narayan
Neetu Vijay
Pradip Barde
Gita Nataraj
Amrutha Kumari B.
Manasa P. Kumari
Debasis Biswas
Jyoti Iravane
Sharmila Raut
Shanta Dutta
Sulochana Devi
Purnima Barua
Piyali Gupta
Biswa Borkakoty
Deepjyoti Kalita
Kanwardeep Dhingra
Bashir Fomda
Yash Joshi
Kapil Goyal
Reena John
Ashok Munivenkatappa 
Rahul Dhodapkar
Priyanka Pandit
Sarada Devi
Manisha Dudhmal
Deepa Kinariwala
Neeta Khandelwal
Yogendra Kumar Tiwari
Prabhat Kiran Khatri
Anjli Gupta
Himanshu Khatri
Bharti Malhotra
Mythily Nagasundaram
Lalit Dar
Nazira Sheikh
Jayanthi Shastri
Neeraj Aggarwal
Priya Abraham
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India
Viruses
breakthrough
COVID-19
VRDL
Delta and Delta plus variant
India
vaccine
title Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India
title_full Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India
title_fullStr Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India
title_full_unstemmed Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India
title_short Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India
title_sort clinical characterization and genomic analysis of samples from covid 19 breakthrough infections during the second wave among the various states of india
topic breakthrough
COVID-19
VRDL
Delta and Delta plus variant
India
vaccine
url https://www.mdpi.com/1999-4915/13/9/1782
work_keys_str_mv AT niveditagupta clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT harmanmeetkaur clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT pragyadhruvyadav clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT labanyamukhopadhyay clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT rimarsahay clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT abhinendrakumar clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT dimpalanyayanit clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT anitamshete clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT savitapatil clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT triparnamajumdar clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT salajrana clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT swatigupta clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT jitendranarayan clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT neetuvijay clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT pradipbarde clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT gitanataraj clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT amruthakumarib clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT manasapkumari clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT debasisbiswas clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT jyotiiravane clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT sharmilaraut clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT shantadutta clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT sulochanadevi clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT purnimabarua clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT piyaligupta clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT biswaborkakoty clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT deepjyotikalita clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT kanwardeepdhingra clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT bashirfomda clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT yashjoshi clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT kapilgoyal clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT reenajohn clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT ashokmunivenkatappa clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT rahuldhodapkar clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT priyankapandit clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT saradadevi clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT manishadudhmal clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT deepakinariwala clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT neetakhandelwal clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT yogendrakumartiwari clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT prabhatkirankhatri clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT anjligupta clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT himanshukhatri clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT bhartimalhotra clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT mythilynagasundaram clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT lalitdar clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT nazirasheikh clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT jayanthishastri clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT neerajaggarwal clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia
AT priyaabraham clinicalcharacterizationandgenomicanalysisofsamplesfromcovid19breakthroughinfectionsduringthesecondwaveamongthevariousstatesofindia